A detailed history of Fieldpoint Private Securities, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 15 shares of CRL stock, worth $2,818. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15
Previous 60 75.0%
Holding current value
$2,818
Previous $17,000 82.35%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$204.13 - $302.4 $9,185 - $13,607
-45 Reduced 75.0%
15 $3,000
Q1 2022

Apr 07, 2022

BUY
$255.51 - $362.11 $1,277 - $1,810
5 Added 9.09%
60 $17,000
Q1 2021

Apr 23, 2021

BUY
$249.67 - $299.48 $1,248 - $1,497
5 Added 10.0%
55 $16,000
Q4 2020

Jan 28, 2021

BUY
$222.0 - $252.62 $11,100 - $12,631
50 New
50 $12,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.56B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Fieldpoint Private Securities, LLC Portfolio

Follow Fieldpoint Private Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.